A case showed a patient with stage IB NRG1-positive lung cancer expressing significant higher level of NRG1β had an overall survival (OS) of 39 months [8], which was much shorter than the median OS of patients with stage I NRG1-positive lung cancers [2]. This evidence concerns the gene NRG1 and lung carcinoma.